# Ajanta Pharma USA Inc – FDA Inspection, Jul 22, 2025

Source: https://www.keypedia.com/records/fda_inspections/ajanta-pharma-usa-inc/659b0944-41d5-43b5-a2ed-eb7d4abb5387
Source feed: FDA_Inspections

> FDA inspection 1276284 of Ajanta Pharma USA Inc, July 22, 2025. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 314. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1276284
- Company Name: Ajanta Pharma USA Inc
- Inspection Date: 2025-07-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Postmarketing Surveillance and Epidemiology: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New Jersey District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1049436 - 2018-04-04
- [FDA Inspection 965140 - 2016-03-17](https://www.keypedia.com/records/fda_inspections/ajanta-pharma-usa-inc/923413a9-339f-459b-b453-59bc8a5fed91)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jay-b-shah/c437fff9-807e-4dea-80c0-8f77850db6f8)

Company: https://www.keypedia.com/companies/ajanta-pharma-usa-inc/fb94ebd3-ce80-4426-8f91-9f82716e5ea6

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248
